Insider Trading activities of Quest Diagnostics Inc insiders. , Part 2

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Quest Diagnostics Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Quest Diagnostics Inc since year 2005. (See page 1 of this report.) Table 2 shows the detailed insider transactions of Quest Diagnostics Inc since 2005. The reporting company's ticker symbol is DGX. The reporting company's CIK number is 1022079.
The total value of stock buying since 2005 is $1,959,690.
The total value of stock sales since 2005 is $2,353,060,911.
The total value of stock option exercises since 2005 is $239,902,537.


 1   2   3 

Table 2. Detailed insider stock purchases, sales, and option exercises of Quest Diagnostics Inc insiders (DGX) , Part 2
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2013-10-29 Bongiorno Thomas F (VP and Corporate Controller) Option Ex 6,000 40.43 242,567
2013-10-25 Pfeiffer Gary M (Director) Sale 2,000 58.10 116,200
2013-09-17 Doherty Catherine T. (SVP, Clinical Franchises) Sale 27,621 62.00 1,712,502
2013-09-17 Doherty Catherine T. (SVP, Clinical Franchises) Option Ex 27,621 52.24 1,443,059
2013-09-16 Doherty Catherine T. (SVP, Clinical Franchises) Sale 15,713 62.00 974,206
2013-09-16 Doherty Catherine T. (SVP, Clinical Franchises) Option Ex 15,713 52.24 820,925
2013-08-14 Doherty Catherine T. (SVP, Clinical Franchises) Sale 33,000 59.85 1,975,116
2013-08-14 Doherty Catherine T. (SVP, Clinical Franchises) Option Ex 33,000 40.43 1,334,124
2013-08-12 Ziegler John B (Director) Sale 1,953 59.45 116,109
2013-08-08 Bongiorno Thomas F (VP and Corporate Controller) Sale 10,864 59.33 644,582
2013-08-08 Bongiorno Thomas F (VP and Corporate Controller) Option Ex 12,000 40.43 485,135
2013-07-23 Britell Jenne K (Director) Sale 4,200 58.99 247,766
2013-06-18 Prevoznik Michael E (SVP & General Counsel) Sale 9,921 62.46 619,685
2013-06-18 Prevoznik Michael E (SVP & General Counsel) Option Ex 9,921 40.43 401,086
2013-06-17 Prevoznik Michael E (SVP & General Counsel) Sale 116,746 62.65 7,314,487
2013-06-17 Prevoznik Michael E (SVP & General Counsel) Option Ex 116,746 46.34 5,409,542
2013-05-22 Ziegler John B (Director) Sale 31,362 62.00 1,944,444
2013-05-22 Ziegler John B (Director) Option Ex 31,362 44.57 1,397,678
2013-05-14 Baldwin John C Md (Director) Sale 1,214 59.41 72,122
2013-05-02 Wilensky Gail R (Director) Sale 10,000 57.20 572,010
2013-05-02 Wilensky Gail R (Director) Option Ex 10,000 55.40 554,000
2013-04-11 Ziegler John B (Director) Sale 1,470 58.35 85,774
2013-04-11 Ziegler John B (Director) Option Ex 1,470 38.96 57,268
2013-03-06 Prevoznik Michael E (SVP & General Counsel) Sale 2,770 56.64 156,892
2013-02-20 Ziegler John B (Director) Sale 2,000 57.42 114,840
2013-02-20 Britell Jenne K (Director) Sale 10,000 57.30 572,960
2013-02-20 Britell Jenne K (Director) Option Ex 10,000 55.40 554,000
2013-02-19 Prevoznik Michael E (SVP & General Counsel) Sale 1,442 57.53 82,961
2013-02-12 Prevoznik Michael E (SVP & General Counsel) Sale 3,481 57.48 200,073
2013-01-17 Pfeiffer Gary M (Director) Sale 10,000 60.00 600,000
2013-01-17 Pfeiffer Gary M (Director) Option Ex 10,000 55.40 554,000
2012-10-03 Hagemann Robert (SVP & Chief Financial Officer) Sale 46,667 64.00 2,986,688
2012-10-03 Hagemann Robert (SVP & Chief Financial Officer) Option Ex 46,667 40.43 1,886,653
2012-09-06 Ziegler John B (Director) Sale 10,000 62.32 623,190
2012-09-06 Ziegler John B (Director) Option Ex 10,000 55.40 554,000
2012-08-15 Wilensky Gail R (Director) Sale 20,000 59.24 1,184,720
2012-08-15 Wilensky Gail R (Director) Option Ex 20,000 30.45 609,100
2012-08-10 Buehler William F (Director) Sale 30,000 59.29 1,778,640
2012-08-10 Buehler William F (Director) Option Ex 30,000 42.93 1,287,840
2012-08-08 Doherty Catherine T. (SVP, Physician Services) Sale 40,000 60.11 2,404,320
2012-08-08 Doherty Catherine T. (SVP, Physician Services) Option Ex 40,000 52.23 2,089,400
2012-08-08 Baldwin John C Md (Director) Sale 11,770 59.99 706,082
2012-08-08 Baldwin John C Md (Director) Option Ex 10,000 55.40 554,000
2012-08-07 Rusckowski Stephen H (President and CEO) Buy 5,000 59.34 296,675
2012-08-03 Ziegler John B (Director) Sale 2,800 59.26 165,916
2012-08-01 Prevoznik Michael E (SVP & General Counsel) Sale 86,445 58.68 5,072,333
2012-08-01 Prevoznik Michael E (SVP & General Counsel) Option Ex 86,445 38.50 3,327,959
2012-07-31 Prevoznik Michael E (SVP & General Counsel) Sale 28,814 58.59 1,688,269
2012-07-31 Prevoznik Michael E (SVP & General Counsel) Option Ex 40,222 24.76 995,896
2012-07-12 Stanzione Daniel (Director) Sale 30,000 62.00 1,860,000
2012-07-12 Stanzione Daniel (Director) Option Ex 30,000 42.93 1,287,840
2012-06-29 Bongiorno Thomas F (VP and Corporate Controller) Sale 15,000 59.54 893,100
2012-06-29 Bongiorno Thomas F (VP and Corporate Controller) Option Ex 15,000 52.23 783,525
2012-06-29 Ziegler John B (Director) Sale 1,460 60.00 87,600
2012-06-29 Ziegler John B (Director) Option Ex 1,460 31.12 45,436
2012-06-28 Ziegler John B (Director) Sale 20,000 59.00 1,180,000
2012-06-28 Ziegler John B (Director) Option Ex 20,000 30.45 609,100
2012-05-30 Ziegler John B (Director) Sale 864 58.13 50,224
2012-05-30 Ziegler John B (Director) Option Ex 864 29.35 25,358
2012-05-08 Bongiorno Thomas F (VP and Corporate Controller) Sale 1 56.83 56
2012-05-08 Rusckowski Stephen H (President and CEO) Buy 20,000 56.89 1,137,740
2012-05-02 Pfeiffer Gary M (Director) Sale 10,000 58.30 583,040
2012-05-02 Pfeiffer Gary M (Director) Option Ex 10,000 53.27 532,670
2012-05-01 Baldwin John C Md (Director) Sale 10,334 57.50 594,205
2012-05-01 Baldwin John C Md (Director) Option Ex 8,000 49.94 399,520
2012-05-01 Bongiorno Thomas F (VP and Corporate Controller) Sale 2,305 58.43 134,685
2012-04-02 Hagemann Robert (SVP & Chief Financial Officer) Sale 46,666 62.00 2,893,292
2012-04-02 Hagemann Robert (SVP & Chief Financial Officer) Option Ex 46,666 40.43 1,886,613
2012-03-01 Prevoznik Michael E (SVP & General Counsel) Sale 7,207 57.40 413,652
2012-02-24 Miller Joan Elizabeth (SVP-Oncology & Neurology Srvcs) Sale 15,561 57.45 893,979
2012-02-24 Miller Joan Elizabeth (SVP-Oncology & Neurology Srvcs) Option Ex 15,561 56.23 875,072
2012-02-21 Bongiorno Thomas F (VP and Corporate Controller) Sale 7,078 57.50 406,985
2012-02-21 Bongiorno Thomas F (VP and Corporate Controller) Option Ex 7,078 56.87 402,554
2012-02-16 Prevoznik Michael E (SVP & General Counsel) Sale 1,462 57.38 83,888
2012-02-14 Prevoznik Michael E (SVP & General Counsel) Sale 4,544 57.39 260,784
2012-02-03 Miller Joan Elizabeth (SVP-Oncology & Neurology Srvcs) Sale 13,333 58.50 779,980
2012-02-03 Miller Joan Elizabeth (SVP-Oncology & Neurology Srvcs) Option Ex 13,333 55.65 741,981
2012-02-01 Mohapatra Surya N (Chairman, President & CEO) Sale 20,556 58.38 1,200,018
2012-02-01 Mohapatra Surya N (Chairman, President & CEO) Option Ex 20,556 48.74 1,001,899
2012-01-30 Mohapatra Surya N (Chairman, President & CEO) Sale 90,000 58.17 5,235,480
2012-01-27 Mohapatra Surya N (Chairman, President & CEO) Sale 119,732 59.04 7,068,977
2012-01-27 Mohapatra Surya N (Chairman, President & CEO) Option Ex 119,732 40.43 4,840,525
2012-01-27 Stanzione Daniel (Director) Sale 30,000 59.00 1,770,000
2012-01-27 Stanzione Daniel (Director) Option Ex 30,000 50.37 1,510,980
2012-01-27 Wilensky Gail R (Director) Sale 30,000 58.94 1,768,140
2012-01-27 Wilensky Gail R (Director) Option Ex 30,000 50.37 1,510,980
2012-01-26 Baldwin John C Md (Director) Sale 10,000 59.00 590,010
2012-01-26 Baldwin John C Md (Director) Option Ex 10,000 53.27 532,670
2012-01-26 Hagemann Robert (SVP & Chief Financial Officer) Sale 113,334 59.37 6,728,979
2012-01-26 Hagemann Robert (SVP & Chief Financial Officer) Option Ex 113,334 52.23 5,920,001
2012-01-26 Mohapatra Surya N (Chairman, President & CEO) Sale 220,268 59.12 13,022,464
2012-01-26 Mohapatra Surya N (Chairman, President & CEO) Option Ex 220,268 40.43 8,904,994
2012-01-26 Buehler William F (Director) Sale 30,000 58.83 1,764,780
2012-01-26 Buehler William F (Director) Option Ex 30,000 50.37 1,510,980
2012-01-03 Mohapatra Surya N (Chairman, President & CEO) Sale 20,556 58.66 1,205,856
2012-01-03 Mohapatra Surya N (Chairman, President & CEO) Option Ex 20,556 48.74 1,001,899
2011-12-21 Hagemann Robert (SVP & Chief Financial Officer) Sale 4,150 57.75 239,658
2011-12-21 Hagemann Robert (SVP & Chief Financial Officer) Option Ex 4,150 42.14 174,864
2011-12-01 Hagemann Robert (SVP & Chief Financial Officer) Sale 4,150 58.16 241,368
2011-12-01 Hagemann Robert (SVP & Chief Financial Officer) Option Ex 4,150 42.14 174,864
2011-12-01 Mohapatra Surya N (Chairman, President & CEO) Sale 20,556 57.95 1,191,179
2011-12-01 Mohapatra Surya N (Chairman, President & CEO) Option Ex 20,556 48.74 1,001,899
2011-11-21 Hagemann Robert (SVP & Chief Financial Officer) Sale 4,150 54.40 225,760
2011-11-21 Hagemann Robert (SVP & Chief Financial Officer) Option Ex 4,150 42.14 174,864
2011-11-08 Bongiorno Thomas F (VP and Corporate Controller) Sale 13,334 57.50 766,705
2011-11-08 Bongiorno Thomas F (VP and Corporate Controller) Option Ex 13,334 48.74 649,899
2011-11-03 Britell Jenne K (Director) Sale 7,500 55.70 417,750
2011-11-03 Britell Jenne K (Director) Option Ex 7,500 47.45 355,875
2011-11-01 Hagemann Robert (SVP & Chief Financial Officer) Sale 4,150 54.81 227,457
2011-11-01 Hagemann Robert (SVP & Chief Financial Officer) Option Ex 4,150 42.14 174,864
2011-11-01 Mohapatra Surya N (Chairman, President & CEO) Sale 20,556 54.69 1,124,145
2011-11-01 Mohapatra Surya N (Chairman, President & CEO) Option Ex 20,556 48.74 1,001,899
2011-10-28 Miller Joan Elizabeth (SVP-Oncology & Neurology Srvcs) Sale 19,259 57.50 1,107,392
2011-10-28 Miller Joan Elizabeth (SVP-Oncology & Neurology Srvcs) Option Ex 19,259 52.23 1,005,993
2011-10-28 Ziegler John B (Director) Sale 12,997 57.28 744,494
2011-10-28 Ziegler John B (Director) Option Ex 12,997 52.38 680,795
2011-10-28 Mohapatra Surya N (Chairman, President & CEO) Sale 50,000 57.41 2,870,500
2011-10-28 Mohapatra Surya N (Chairman, President & CEO) Option Ex 50,000 24.76 1,238,000
2011-10-27 Prevoznik Michael E (SVP & General Counsel) Sale 116,000 56.68 6,574,880
2011-10-27 Prevoznik Michael E (SVP & General Counsel) Option Ex 116,000 42.14 4,887,776
2011-10-25 Mohapatra Surya N (Chairman, President & CEO) Sale 48,047 56.49 2,714,175
2011-10-25 Mohapatra Surya N (Chairman, President & CEO) Option Ex 48,047 48.74 2,341,810
2011-10-21 Hagemann Robert (SVP & Chief Financial Officer) Sale 4,150 49.29 204,553
2011-10-21 Hagemann Robert (SVP & Chief Financial Officer) Option Ex 4,150 42.14 174,864
2011-10-03 Hagemann Robert (SVP & Chief Financial Officer) Sale 4,150 49.23 204,300
2011-10-03 Hagemann Robert (SVP & Chief Financial Officer) Option Ex 4,150 42.14 174,864
2011-09-21 Hagemann Robert (SVP & Chief Financial Officer) Sale 4,150 49.51 205,478
2011-09-21 Hagemann Robert (SVP & Chief Financial Officer) Option Ex 4,150 42.14 174,864
2011-09-01 Hagemann Robert (SVP & Chief Financial Officer) Sale 4,150 49.97 207,383
2011-09-01 Hagemann Robert (SVP & Chief Financial Officer) Option Ex 4,150 42.14 174,864
2011-08-29 Hagemann Robert (SVP & Chief Financial Officer) Sale 4,150 49.00 203,350
2011-08-29 Hagemann Robert (SVP & Chief Financial Officer) Option Ex 4,150 42.14 174,864
2011-08-17 Bongiorno Thomas F (VP and Corporate Controller) Sale 1,500 49.29 73,938
2011-07-21 Hagemann Robert (SVP & Chief Financial Officer) Sale 4,150 57.19 237,350
2011-07-21 Hagemann Robert (SVP & Chief Financial Officer) Option Ex 4,150 42.14 174,864
2011-07-01 Hagemann Robert (SVP & Chief Financial Officer) Sale 4,150 58.99 244,804
2011-07-01 Hagemann Robert (SVP & Chief Financial Officer) Option Ex 4,150 42.14 174,864
2011-07-01 Mohapatra Surya N (Chairman, President & CEO) Sale 20,555 58.96 1,211,963
2011-07-01 Mohapatra Surya N (Chairman, President & CEO) Option Ex 20,555 48.74 1,001,850
2011-06-21 Hagemann Robert (SVP & Chief Financial Officer) Sale 4,150 60.67 251,801
2011-06-21 Hagemann Robert (SVP & Chief Financial Officer) Option Ex 4,150 42.14 174,864
2011-06-16 Miller Joan Elizabeth (SVP-Oncology & Neurology Srvcs) Sale 3,815 60.20 229,663
2011-06-16 Simmons Wayne R. (Vice President, Operations) Sale 16,000 60.00 960,000
2011-06-16 Simmons Wayne R. (Vice President, Operations) Option Ex 16,000 48.74 779,840
2011-06-14 Miller Joan Elizabeth (SVP-Oncology & Neurology Srvcs) Sale 4,668 59.70 278,679
2011-06-13 Miller Joan Elizabeth (SVP-Oncology & Neurology Srvcs) Sale 10,615 59.20 628,408
2011-06-01 Hagemann Robert (SVP & Chief Financial Officer) Sale 4,150 58.10 241,110
2011-06-01 Hagemann Robert (SVP & Chief Financial Officer) Option Ex 4,150 42.14 174,864
2011-06-01 Mohapatra Surya N (Chairman, President & CEO) Sale 20,555 58.06 1,193,505
2011-06-01 Mohapatra Surya N (Chairman, President & CEO) Option Ex 20,555 48.74 1,001,850
 1   2   3 

Insider trading activities including stock purchases, stock sales, and option exercises of DGX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Quest Diagnostics Inc (symbol DGX, CIK number 1022079) see the Securities and Exchange Commission (SEC) website.